Detection of a Recombinant Murine Leukemia Virus-Related Glycoprotein on Virus-Negative Thymoma Cells (Envelope Glycoprotein/Lymphoma) PETER J

Total Page:16

File Type:pdf, Size:1020Kb

Detection of a Recombinant Murine Leukemia Virus-Related Glycoprotein on Virus-Negative Thymoma Cells (Envelope Glycoprotein/Lymphoma) PETER J Proc. Natl. Acad. Sci. USA Vol. 78, No. 3, pp. 1920-1924, March 1981 Microbiology Detection of a recombinant murine leukemia virus-related glycoprotein on virus-negative thymoma cells (envelope glycoprotein/lymphoma) PETER J. FISCHINGER*, H. JURGEN THIELt, JAMES N. IHLEt, JOHN C. LEEO, AND JOHN H. ELDER§ *Lboratory of Viral Carcinogenesis, National Cancer Institute, Frederick, Maryland 21701; tDepartment of Surgery, Duke University, Durham, North Carolina 27710; NFrederick Cancer Research Center, Frederick, Maryland 21701; and §Scripps Clinic and Research Foundation, La Jolla, California 92037 Communicated by Charlotte Friend, November 6, 1980 ABSTRACT X-irradiation of outbred Swiss mice resulted in tion-induced C57BL lymphomas do not overtly express MuLV, the development of virus-free thymomas. When put in culture, it has been possible to isolate a transmissible leukemogenic a lymphoblastic cell line (NIXT) expressed neither particles nor agent, radiation leukemia virus (RadLV), which has unique env infectious virus but supported the growth of pure ecotropic mu- rine leukemia viruses (MuLVs) without generating any envelope gene characteristics (14-16). Similarly, we have observed that recombinant (RM) MuLV in more than 20 months of culture. radiation-induced leukemias in Swiss mice do not express type These cells did not support the growth of RM-MuLVs and com- C viruses (17). It was possible that such a system could yield pletely excluded the entry of all RM-MuLV pseudotypes of mu- insights as to how leukemogenesis could take place in the ap- rine sarcoma virus, suggesting specific viral interference. Ra- parent absence of MuLV. We now define such a system and dioimmunocompetition and immunofluorescence assays with demonstrate that, in a virus free x-ray-induced thymic lym- broadly reactive anti-MuLV-p30 and -gp7O antisera were nega- tive. However, in immunofluorescence with antisera specifically phoma in an outbred Swiss mouse, there is expression of a reactive against RM-MuLV gp7O, about 5-20% of the population unique surface MuLV RM-like glycoprotein on thymoma cells. of parental cells or their clones were positive. NIXT cells treated with this antiserum bound protein A and exhibited complement- AND dependent cytotoxicity as assessed by several assays. NIXT cells MATERIALS METHODS could partially absorb neutralizing antibody specific for RM- Mice. Outbred Swiss mice were obtained from the Frederick MuLVs. Based on radioimmunoprecipitation tests, NIXT cells Cancer Research Center colony. They were given four weekly bore, on the cell surface, a glycosylated protein (gp70) reactive 175 R x 102 at 1-2 with RM subgroup as well as some group-specific anti-gp7O anti- doses of (4.5 coulomb/kg) age months. sera. The glycoprotein was also found free in the supernates of Thymomas developed in '=80% of mice (17). NIXT cells. Using affinity chromatography, we determined the Cells, Viruses, and Assays. Tumor cells were initially cul- peptide pattern of the gp7O from NIXT cells to determine its struc- tured on RPMI-1640 medium supplemented with 20% fetal calf tural relationship to gp70s of other MuLVs. NIXT gp7O was found serum. The derivative cell line was adapted to McCoy's 5a me- to be highly related to class III endogenous xenotropic gp70s but, dium with 10% fetal calf serum. Outbred Swiss mouse 3T3 FL in addition, had peptide characteristics of RM-gp70s. Apparently, cells, cat embryo diploid fibroblasts (FEF), normal mink lung NIXT cells code for an unusual gp70 protein in the absence of other MuLV expression. The possible role of this glycoprotein in leu- cells, and murine sarcoma virus (MuSV)-positive, leukemia- kemogenesis is discussed. negative (S + L-) mouse and cat cells were grown on the latter medium as described (18-20). Assays for the presence of ter- Murine leukemia viruses (MuLVs) include a number of repli- minal transferase activity and 20a-hydroxysteroid dehydrogen- cating and defective oncovirus types of varying disease-induc- ase activity were performed as described (21). Ecotropic ing potential and of immunologically distinct protein compo- MuLVs included the Friend Eveline strain (F), the Moloney sition (1-4). The genetic information for MuLVs is generally IC strain (M), and the constitutively produced AKR embryo encoded in the mouse DNA as a family of proviral DNA copie cell-derived MuLV. Polytropic envelope recombinant (RM) some of which have been defined as specific genetic loci (5-7 MuLVs included the prototype RM-MHIX virus, an MCF type MuLVs can be divided into those that grow well in mouse cel RM-AKRTU from Tubingen AKR mouse lymphomas, another (ecotropic), those that are restricted from growth in mouse cel RM-Mp from BALB/c lymphomas from Paris, an RM-Gr de- but not in cells of many other species (xenotropic), and those rived from Graffi MuLV stocks, and an RM-MuLV constitui- that grow in both mouse and other cells (1, 8, 9). The last group tively produced by C57BL/6 cells (22). A representative of the is composed of two different subsets: the wild mouse ampho- xenotropic envelope glycoprotein-containing MuLV was the B- tropic, which is different in its envelope properties from eco- MuX isolate (23). Assays for the ml isolate of MuSV and MuLV tropic and xenotropic viruses, and a dual or polytropic group focus-inducing units were as described (18, 19, 23). consisting of recombinant (RM) MuLVs whose env gene se- Immunological Assays. Several rabbit antisera against the quences are derived in part from both ecotropic and xenotropic isolated gp7O and p15 (E) of F-MuLV, and of gp70s of Rauscher MuLV-like sequences (10, 11). The RM group could be onco- (R) MuLV, and the VL-3 isolate of radiation leukemia virus genic in genetically pure form, and it has been suggested that (RadLV) were previously characterized (24, 25). Radioimmu- it is the RM variant that is the actual leukemogenic agent in a noassays for individual MuLV viral proteins were performed number of spontaneous or transmitted lymphocytic leukemias (12, 13). Abbreviations: NIXT, non-virus-producing, X-irradiation-induced Swiss A role for these viruses in primary leu- mouse thymoma cell line; MuLV, murine leukemia virus; F, M, and radiation-induced R, Friend, Moloney, and Rauscher, respectively; RM, recombinant kemias has been less obvious. Although the majority of radia- murine virus; S+L-, sarcoma-positive, leukemia-negative; MuX, mu- rine xenotropic MuLV; MuSV murine sarcoma virus; RM-Mj1jx, RM- The publication costs of this article were defrayed in part by page charge Mp, RM-Gr, and RM-AKR and RM-MuLVs, the first two isolated from payment. This article must therefore be hereby marked "advertise- M-MuLV and the latter, from Graffi and AKR MuLVs, respectively; ment" in accordance with 18 U. S. C. §1734 solely to indicate this fact. RadLV, radiation leukemia virus. 1920 Downloaded by guest on September 24, 2021 Microbiology: Fischinger et aL Proc. NatL Acad. Sci. USA 78 (1981) 1921 according to standard procedures (25). Neutralizations and ab- Table 1. Growth of various MuLV isolates in NIXT cells sorption of antibody with infected cells were performed as de- Early harvests Late harvests scribed (24). Two types of cytotoxic assays were performed, the first being a reduction of cloning efficiency of cells in the pres- MULV assayed on assayed on inoculum Mouse S+L- Cat S+L- Mouse S+L- Cat S+L- ence of antiserum and low toxicity to mouse lymphocytes rabbit complement (Cedarlane Labs, Ontario, Canada). 51Cr release Ecotropic: assays were performed by using rabbit (Pel-Freeze) comple- M 5.1 x 104 0 1.2 x 104 0 ment and assorted antisera as described (26). Lactoperoxidase- F 5.0 x 104 0 1.4 x 104 0 catalyzed cell surface iodination and metabolic labeling of cells AKR 2.0 x 103 0 5.0 x 102* generally followed published procedures (27). The precipitates RM: were analyzed on slab gels (28) and processed by fluorography RM-MHa 0 0 0 0 0 0 0 (29). Binding assays of antiserum and "2I-labeled protein A to RM-Mp 0 cells followed published procedures (30). RM-AKRT 0 0 NT NT and RM-C57 0 0 Peptide Patterns. Two-dimensional tryptic chymotryptic Xenotropic: peptide patterns (fingerprints) were determined on the gp7O B-MuX 0 0 present free in the supernates and in Nonidet P40 lysates of NIXT cells as described (31). Data are shown as focus-inducing units per ml of supernate. RM- MuLV- and B-MuX-infected NIXT cells were discarded after 4 weeks of infection when assays in both mouse and cat S+L- cells were neg- RESULTS ative. Negatives represent a minimum of six assays for each set over a 1-year period. NT, not tested. Development of the NIXT Cell Line. A tumor-bearing 4- - Average titers; AKR-MuLV was lost from infected NIXT cells after month-old mouse was sacrificed and the finely minced thymic about 1 year. tumor was put in culture. An adherent feeder layer developed; after several weeks, there was an increase in nonadherent cells. 0.1, with the ml isolate of MuSV pseudotyped with RM-MHIX, Rapid growth of small lymphoblastoid cells and clusters ensued RM-AKRTU, RM-Gr, and RM-C57 envelopes and in a second in the absence of feeder layers. The culture growth and cell set coinfected with ecotropic M-MuLV at a multiplicity of 0.2. characteristics remained unchanged for 18 months. No virus Supernates were harvested daily after infection and assayed in particles were seen in thin sections. The optimal dividing time mink lung, FEF, and mouse and cat S+L- cells. No focus- of cells was -14 hr, and the cells regularly grew in suspension forming MuSV was detected as long as 1 month after infection to =5 X 106 cells per ml with 2% fetal calf serum.
Recommended publications
  • Direct Agroinoculation of Maize Seedlings by Injection with Recombinant Foxtail Mosaic Virus and Sugarcane Mosaic Virus Infectious Clones
    Direct Agroinoculation of Maize Seedlings by Injection with Recombinant Foxtail Mosaic Virus and Sugarcane Mosaic Virus Infectious Clones Bliss M. Beernink*,1, Katerina L. Holan*,1, Ryan R. Lappe1, Steven A. Whitham1 1 Department of Plant Pathology and Microbiology, Iowa State University * These authors contributed equally Corresponding Author Abstract Steven A. Whitham [email protected] Agrobacterium-based inoculation approaches are widely used for introducing viral vectors into plant tissues. This study details a protocol for the injection of maize Citation seedlings near meristematic tissue with Agrobacterium carrying a viral vector. Beernink, B.M., Holan, K.L., Lappe, R.R., Recombinant foxtail mosaic virus (FoMV) clones engineered for gene silencing and Whitham, S.A. Direct Agroinoculation of Maize Seedlings by Injection with gene expression were used to optimize this method, and its use was expanded Recombinant Foxtail Mosaic Virus and to include a recombinant sugarcane mosaic virus (SCMV) engineered for gene Sugarcane Mosaic Virus Infectious Clones. J. Vis. Exp. (168), e62277, expression. Gene fragments or coding sequences of interest are inserted into a doi:10.3791/62277 (2021). modified, infectious viral genome that has been cloned into the binary T-DNA plasmid vector pCAMBIA1380. The resulting plasmid constructs are transformed into Date Published Agrobacterium tumefaciens strain GV3101. Maize seedlings as young as 4 days February 27, 2021 old can be injected near the coleoptilar node with bacteria resuspended in MgSO4 DOI
    [Show full text]
  • Recombinant and Chimeric Viruses
    Recombinant and chimeric viruses: Evaluation of risks associated with changes in tropism Ben P.H. Peeters Animal Sciences Group, Wageningen University and Research Centre, Division of Infectious Diseases, P.O. Box 65, 8200 AB Lelystad, The Netherlands. May 2005 This report represents the personal opinion of the author. The interpretation of the data presented in this report is the sole responsibility of the author and does not necessarily represent the opinion of COGEM or the Animal Sciences Group. Dit rapport is op persoonlijke titel door de auteur samengesteld. De interpretatie van de gepresenteerde gegevens komt geheel voor rekening van de auteur en representeert niet de mening van de COGEM, noch die van de Animal Sciences Group. Advisory Committee Prof. dr. R.C. Hoeben (Chairman) Leiden University Medical Centre Dr. D. van Zaane Wageningen University and Research Centre Dr. C. van Maanen Animal Health Service Drs. D. Louz Bureau Genetically Modified Organisms Ing. A.M.P van Beurden Commission on Genetic Modification Recombinant and chimeric viruses 2 INHOUDSOPGAVE RECOMBINANT AND CHIMERIC VIRUSES: EVALUATION OF RISKS ASSOCIATED WITH CHANGES IN TROPISM Executive summary............................................................................................................................... 5 Introduction............................................................................................................................................ 7 1. Genetic modification of viruses .................................................................................................9
    [Show full text]
  • Western Equine Encephalitis Virus Is a Recombinant Virus (RNA Recombination/Alphavirus/Evolution of RNA Viruses) CHANG S
    Proc. Natl. Acad. Sci. USA Vol. 85, pp. 5997-6001, August 1988 Evolution Western equine encephalitis virus is a recombinant virus (RNA recombination/Alphavirus/evolution of RNA viruses) CHANG S. HAHN, SHLOMO LUSTIG*, ELLEN G. STRAUSS, AND JAMES H. STRAUSSt Division of Biology, 156-29, California Institute of Technology, Pasadena, CA 91125 Communicated by James Bonner, April 14, 1988 ABSTRACT The alphaviruses are a group of 26 mosquito- virus; O'Nyong-nyong virus; and Ross River virus. Sindbis borne viruses that cause a variety of human diseases. Many of and Semliki Forest viruses have been intensively studied as the New World alphaviruses cause encephalitis, whereas the models for alphavirus replication (7). Sindbis virus is widely Old World viruses more typically cause fever, rash, and distributed, being found in Europe, India, southeast Asia, arthralgia. The genome is a single-stranded nonsegmented Australia, and Africa. Close relatives of this virus, such as RNA molecule of + polarity; it is about 11,700 nucleotides in Ockelbo virus in Europe (8) and Babanki virus in Africa, length. Several alphavirus genomes have been sequenced in cause disease in humans characterized by fever, rash, and whole or in part, and these sequences demonstrate that alpha- arthritis. Chikungunya and O'Nyong-nyong viruses have viruses have descended from a common ancestor by divergent caused large epidemics in Africa of a dengue-like disease also evolution. We have now obtained the sequence of the 3'- characterized by fever, rash, and arthralgia. Ross River virus terminal 4288 nucleotides of the RNA of the New World is the causative agent of epidemic polyarthritis in Australia Alphavirus western equine encephalitis virus (WEEV).
    [Show full text]
  • Recombinant Influenza H9N2 Virus with a Substitution of H3
    www.nature.com/scientificreports OPEN Recombinant infuenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane Received: 4 September 2017 Accepted: 30 November 2017 domain showed enhanced Published: xx xx xxxx immunogenicity in mice and chicken Yun Zhang , Ying Wei, Kang Liu, Mengjiao Huang, Ran Li, Yang Wang, Qiliang Liu, Jing Zheng, Chunyi Xue & Yongchang Cao In recent years, avian infuenza virus H9N2 undergoing antigenic drift represents a threat to poultry farming as well as public health. Current vaccines are restricted to inactivated vaccine strains and their related variants. In this study, a recombinant H9N2 (H9N2-TM) strain with a replaced H3 hemagglutinin (HA) transmembrane (TM) domain was generated. Virus assembly and viral protein composition were not afected by the transmembrane domain replacement. Further, the recombinant TM-replaced H9N2-TM virus could provide better inter-clade protection in both mice and chickens against H9N2, suggesting that the H3-TM-replacement could be considered as a strategy to develop efcient subtype- specifc H9N2 infuenza vaccines. H9N2 avian infuenza virus was frst isolated in turkeys in 19661. Since then, it became prevalent in poultry farming worldwide, resulting in egg production reduction and high mortality when co-infected with other path- ogens2,3. Also, it could cross host-species barrier and cause human infections as reported in China4,5. Tough it is not highly pathogenic as H5N1, researches revealed that it could re-assort with multiple other infuenza subtypes and thus be “gene donor” for H5N1 and H7N9 viruses6–8. Terefore, control of the H9N2 infuenza virus is of great concern. Vaccination utilizing vaccine strains and their relevant variants is the main strategy to control H9N2 pan- demics in the poultry industry of China.
    [Show full text]
  • HIV Virology and Pathogenetic Mechanisms of Infection: a Brief Overview I Ence Exper
    ANN IST SUPER SANITÀ 2010 | VOL. 46, NO. 1: 5-14 5 DOI: 10.4415/ANN_10_01_02 HIV virology and pathogenetic mechanisms ENCE of infection: a brief overview I EXPER (a) (b) (b) (a) L Emanuele Fanales-Belasio , Mariangela Raimondo , Barbara Suligoi and Stefano Buttò A C (a)Centro Nazionale AIDS, Istituto Superiore di Sanità, Rome, Italy I N (b)Centro Operativo AIDS, Dipartimento di Malattie Infettive, Parassitarie ed Immunomediate, I CL Istituto Superiore di Sanità, Rome, Italy TO NG I Summary. Studies on HIV virology and pathogenesis address the complex mechanisms that result TEST in the HIV infection of the cell and destruction of the immune system. These studies are focused L on both the structure and the replication characteristics of HIV and on the interaction of the A M virus with the host. Continuous updating of knowledge on structure, variability and replication I N of HIV, as well as the characteristics of the host immune response, are essential to refine virologi- A cal and immunological mechanisms associated with the viral infection and allow us to identify key molecules in the virus life cycle that can be important for the design of new diagnostic assays FROM and specific antiviral drugs and vaccines. In this article we review the characteristics of molecular structure, replication and pathogenesis of HIV, with a particular focus on those aspects that are RCH important for the design of diagnostic assays. A Key words: HIV, virus replication, antigenic variation, virulence. ESE R Riassunto (La virologia dell’HIV e i meccanismi patogenetici dell’infezione: una breve panoramica). Gli studi sulla virologia e la patogenesi dell’HIV sono importanti per comprendere i complessi meccanismi che regolano l’infezione della cellula da parte del virus e la distruzione del sistema immunitario.
    [Show full text]
  • View of the Manuscript
    Virology Journal BioMed Central Research Open Access Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine Mark N Prichard*1, Earl R Kern1, Debra C Quenelle1, Kathy A Keith1, Richard W Moyer2 and Peter C Turner2 Address: 1Department of Pediatrics, University of Alabama School of Medicine, Birmingham, AL 35233, USA and 2Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, FL 32610, USA Email: Mark N Prichard* - [email protected]; Earl R Kern - [email protected]; Debra C Quenelle - [email protected]; Kathy A Keith - [email protected]; Richard W Moyer - [email protected]; Peter C Turner - [email protected] * Corresponding author Published: 5 March 2008 Received: 24 January 2008 Accepted: 5 March 2008 Virology Journal 2008, 5:39 doi:10.1186/1743-422X-5-39 This article is available from: http://www.virologyj.com/content/5/1/39 © 2008 Prichard et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The vaccinia virus (VV) F2L gene encodes a functional deoxyuridine triphosphatase (dUTPase) that catalyzes the conversion of dUTP to dUMP and is thought to minimize the incorporation of deoxyuridine residues into the viral genome. Previous studies with with a complex, multigene deletion in this virus suggested that the gene was not required for viral replication, but the impact of deleting this gene alone has not been determined in vitro or in vivo.
    [Show full text]
  • REVIEW Viral Vectors for Gene Delivery and Gene Therapy Within the Endocrine System
    103 REVIEW Viral vectors for gene delivery and gene therapy within the endocrine system D Stone, A David, F Bolognani, P R Lowenstein and M G Castro Molecular Medicine and Gene Therapy Unit, Room 1.302, Stopford Building, School of Medicine, University of Manchester, Oxford Road, Manchester M13 9PT, UK (Requests for offprints should be addressed to M G Castro; Email: [email protected]) (F Bolognani is now at INIBIOLP-Histology B, Faculty of Medicine, National University of La Plata, Argentina) Abstract The transfer of genetic material into endocrine cells and use in gene transfer and gene therapy applications. As differ- tissues, both in vitro and in vivo, has been identified as critical ent viral vector systems have their own unique advantages for the study of endocrine mechanisms and the future treat- and disadvantages, they each have applications for which ment of endocrine disorders. Classical methods of gene they are best suited. This review will discuss viral vector transfer, such as transfection, are inefficient and limited systems that have been used for gene transfer into the mainly to delivery into actively proliferating cells in vitro. endocrine system, and recent developments in viral vector The development of viral vector gene delivery systems is technology that may improve their use for endocrine beginning to circumvent these initial setbacks. Several kinds applications – chimeric vectors, viral vector targeting and of viruses, including retrovirus, adenovirus, adeno-associated transcriptional regulation of transgene expression. virus, and herpes simplex virus, have been manipulated for Journal of Endocrinology (2000) 164, 103–118 Introduction ing of transgenes within mammalian cells is an area of rapid development.
    [Show full text]
  • Antiviral Product Development — Conducting and Submitting Virology Studies to the Agency
    Guidance for Industry Antiviral Product Development — Conducting and Submitting Virology Studies to the Agency U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) June 2006 Clinical Antimicrobial Guidance for Industry Antiviral Product Development — Conducting and Submitting Virology Studies to the Agency Additional copies are available from: Office of Training and Communications Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857 (Tel) 301-827-4573 http://www.fda.gov/cder/guidance/index.htm U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) June 2006 Clinical Antimicrobial TABLE OF CONTENTS I. INTRODUCTION............................................................................................................. 1 II. BACKGROUND ............................................................................................................... 2 III. NONCLINICAL VIROLOGY STUDIES ...................................................................... 3 A. Mechanism of Action Studies........................................................................................................3 B. Antiviral Activity ...........................................................................................................................4 1. Antiviral Activity in Vitro.................................................................................................................4
    [Show full text]
  • Yellow Fever Virus Capsid Protein Is a Potent Suppressor of RNA Silencing That Binds Double-Stranded RNA
    Yellow fever virus capsid protein is a potent suppressor of RNA silencing that binds double-stranded RNA Glady Hazitha Samuela, Michael R. Wileyb,1, Atif Badawib, Zach N. Adelmana, and Kevin M. Mylesa,2 aDepartment of Entomology, Texas A&M University, College Station, TX 77843; and bDepartment of Entomology, Fralin Life Science Institute, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061 Edited by George Dimopoulos, Johns Hopkins School of Public Health, Baltimore, MD, and accepted by Editorial Board Member Carolina Barillas-Mury October 6, 2016 (received for review January 13, 2016) Mosquito-borne flaviviruses, including yellow fever virus (YFV), Zika intermediates (RIs) produced during viral infection activate an an- virus (ZIKV), and West Nile virus (WNV), profoundly affect human tiviral defense based on RNA silencing (6). In flies, the ribonuclease health. The successful transmission of these viruses to a human host Dicer-2 (Dcr-2) recognizes dsRNA (7). Cleavage of dsRNA RIs by depends on the pathogen’s ability to overcome a potentially sterilizing Dcr-2 generates viral small interfering RNAs (vsiRNAs) ∼21 nt in immune response in the vector mosquito. Similar to other invertebrate length. These siRNA duplexes are incorporated into the RNA- animals and plants, the mosquito’s RNA silencing pathway comprises induced silencing complex (RISC). RISC maturation involves loading its primary antiviral defense. Although a diverse range of plant and a duplex siRNA, choosing and retaining a guide strand, and ejecting insect viruses has been found to encode suppressors of RNA silencing, the antiparallel passenger strand (8–11). The guide strand directs the mechanisms by which flaviviruses antagonize antiviral small RNA Argonaute 2 (Ago-2), an essential RISC component possessing en- pathways in disease vectors are unknown.
    [Show full text]
  • Harnessing Host–Virus Evolution in Antiviral Therapy and Immunotherapy
    Clinical & Translational Immunology 2019; e1067. doi: 10.1002/cti2.1067 www.wileyonlinelibrary.com/journal/cti SPECIAL FEATURE REVIEW Harnessing host–virus evolution in antiviral therapy and immunotherapy Steven M Heaton Department of Biochemistry & Molecular Biology, Monash University, Clayton, VIC, Australia Correspondence Abstract SM Heaton, Department of Biochemistry & Molecular Biology, Monash University, Pathogen resistance and development costs are major challenges 23 Innovation Walk, Clayton, in current approaches to antiviral therapy. The high error rate of VIC 3800, Australia. RNA synthesis and reverse-transcription confers genome plasticity, E-mail: [email protected] enabling the remarkable adaptability of RNA viruses to antiviral intervention. However, this property is coupled to fundamental Received 30 April 2019; constraints including limits on the size of information available to Revised 7 June 2019; manipulate complex hosts into supporting viral replication. Accepted 9 June 2019 Accordingly, RNA viruses employ various means to extract maximum utility from their informationally limited genomes that, doi: 10.1002/cti2.1067 correspondingly, may be leveraged for effective host-oriented therapies. Host-oriented approaches are becoming increasingly Clinical & Translational Immunology feasible because of increased availability of bioactive compounds 2019; 8: e1067 and recent advances in immunotherapy and precision medicine, particularly genome editing, targeted delivery methods and RNAi. In turn, one driving force behind these innovations is the increasingly detailed understanding of evolutionarily diverse host– virus interactions, which is the key concern of an emerging field, neo-virology. This review examines biotechnological solutions to disease and other sustainability issues of our time that leverage the properties of RNA and DNA viruses as developed through co- evolution with their hosts.
    [Show full text]
  • Libro De Abstract
    SPECIAL THANKS EMPRESAS COLABORADORAS SEV VI R O L O G Í A Publicación Oficial de la Sociedad Española de Virología 13th Spanish National Congress Of Virology Madrid 2015 CONGRESO NACIONAL DE Volumen 18 Número 1/2015 EXTRAORDINARIO VIROLOGÍA . PUBLICACIÓN OFICIAL DE LA SOCIEDAD ESPAÑOLA DE VIROLOGÍA 13th Spanish National Congress Of Virology Madrid 2015 Del 7 al 10 de junio de 2015 Auditorio de la Fábrica Nacional de Moneda y Timbre Real Casa de la Moneda de Madrid Volumen 18 Madrid 2015 Número 1/2015 EXTRAORDINARIO Edición y Coordinación: M Angeles Muñoz-Fernández &M. Dolores García-Alonso Diseño y Maquetación: DM&VCH.events.S.L. Diseño Portada: M. Dolores García-Alonso Impresión: Fragma: Servicios de impresión digital en Madrid ISSN (versión digital): 2172-6523 SEV – Sociedad Española de Virología Centro de Biología Molecular “Severo Ochoa” C/ Nicolás Cabrera, 1 28049 Cantoblanco – Madrid [email protected] Página web del congreso: www.congresonacionalvirologia2015.com La responsabilidad del contenido de las colaboraciones publicadas corresponderá a sus autores, quienes autorizan la reproducción de sus artículos a la SEV exclusivamente para esta edición. La SEV no hace necesariamente suyas las opiniones o los criterios expresados por sus colaboradores. Virología. Publicación Oficial de la Sociedad Española de Virología XIII CONGRESO NACIONAL DE VIROLOGÍA B I E N V E N I D A El Comité Organizador del XIII Congreso Nacional de Virología (XIII CNV) tiene el placer de comunicaros que éste se celebrará en Madrid, del 7 al 10 de junio de 2015. En el XIII CNV participan conjuntamente la Sociedad Española de Virología (SEV) y la Sociedad Italiana de Virología (SIV), y estará abierto13th a Spanish la participación National de virólogos de Latinoamérica.
    [Show full text]
  • Influenza Virus a H5N1 and H1N1
    Echeverry DM et al. Infl uenza virus A H5N1 and H1N1 647 Infl uenza virus A H5N1 and H1N1: features and zoonotic potential ¤ Virus de Influenza A H5N1 y H1N1: características y potencial zoonótico Os virus da Influenza A H5N1 e H1N1: características e potencial zoonótico Diana M Echeverry 1* , MV; Juan D Rodas 2*, MV, PhD 1Grupo de investigación Biogénesis, Facultad de Ciencias Agrarias, Universidad de Antioquia, AA 1226, Medellín, Colombia. 2Grupo de investigación CENTAURO, Facultad de Ciencias Agrarias, Universidad de Antioquia, AA 1226, Medellín, Colombia. (Recibido: 16 febrero, 2011; aceptado: 25 octubre, 2011) Summary Influenza A viruses which belong to the Orthomyxoviridae family, are enveloped, pleomorphic, and contain genomes of 8 single-stranded negative-sense segments of RNA. Influenza viruses have three key structural proteins: hemagglutinin (HA), neuraminidase (NA) and Matrix 2 (M2). Both HA and NA are surface glycoproteins diverse enough that their serological recognition gives rise to the traditional classification into different subtypes. At present, 16 subtypes of HA (H1-H16) and 9 subtypes of NA (N1- N9) have been identified. Among all the influenza A viruses with zoonotic capacity that have been described, subtypes H5N1 and H1N1, have shown to be the most pathogenic for humans. Direct transmission of influenza A viruses from birds to humans used to be considered a very unlikely event but its possibility to spread from human to human was considered even more exceptional. However, this paradigm changed in 1997 after the outbreaks of zoonotic influenza affecting people from Asia and Europe with strains previously seen only in birds. Considering the susceptibility of pigs to human and avian influenza viruses, and the virus ability to evolve and generate new subtypes, that could more easily spread from pigs to humans, the possibility of human epidemics is a constant menace.
    [Show full text]